NGM·Healthcare·$750M·#292 / 520 in Healthcare
XOMA XOMA Royalty Corporation
39HIGH RISK
CATEGORY BREAKDOWN
GROWTH23
QUALITY40
STABILITY67
VALUATION26
GOVERNANCE12
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+14.1%
23
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
156.7%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
15.4x
26
< 3x strong
Rule of 40
Growth rate plus operating margin
112
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
2.3%
19
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+46.6%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE XOMA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when XOMA's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.